GB Meka
Stocks to watch

ADPT

Compare

Adaptive Biotechnologies Corp · Healthcare

$29.43
▼ 0.5%Close 2026-09-30

Live intraday price

Compare with our price levels

T233.28
T130.81
E124.84
E319.77
SL18.53

Close 2026-09-30: $29.43 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting▼ Leaning negative

Not in the buy zone yet — needs to drop 15.6% · Held by 4 whales

1 month
▲ 12.5%
3 months
▲ 40.4%
1 year
▲ 129.6%
Analyst target
$26.36 -10.4%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$24.84 -15.6%
E2$23.73 -19.4%
E3$19.77 -32.8%
Targets
T1$30.81 4.7%
T2$33.28 13.1%
T3$35.76 21.5%
Stop-loss
SL$18.53 -37.0%
Whale cost ~$14.05 -52.3%

Risk : reward 1 : 2.5Moves ~$1.24 a day

⚖️ Positives and risks

✓ Positives (4)
  • ●แนวโน้มระยะยาวเป็นขาขึ้น (เหนือ MA200 และ MA200 ชี้ขึ้น)
  • ●แข็งแกร่งกว่าตลาด (S&P 500) +92% ใน 6 เดือน
  • ●นักวิเคราะห์ส่วนใหญ่แนะนำ Strong Buy
  • ●รายได้โต +22% เทียบปีก่อน
! Risks (6)
  • ●เซียนขายออก/ลดสัดส่วน 2 ราย: Bridgewater (ลด), Joel Greenblatt (ลด)
  • ●RSI 72 ซื้อมากเกินไป (Overbought) เสี่ยงย่อตัว
  • ●ราคาห่างเหนือ MA200 ถึง +61% วิ่งมาไกลแล้ว
  • ●ราคาเกินเป้าหมายนักวิเคราะห์เฉลี่ย 26.36 แล้ว (-10%)
  • ●บริษัทยังขาดทุน (อัตรากำไรสุทธิติดลบ)
  • ●หนี้สูง D/E 272%

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

LO FRANCIS · Officer

2026-09-16 · 107,537 shares @ $28.02 · pre-planned sale (10b5-1)

$3M
Sell

LO FRANCIS · Officer

2026-09-16 · 7,869 shares @ $28.57 · pre-planned sale (10b5-1)

$224,817
Sell

BOBULSKY SUSAN · Officer

2026-09-15 · 1,195 shares @ $27.00 · pre-planned sale (10b5-1)

$32,265
Sell

OWEN KATEY EINTERZ · Director

2026-08-26 · 9,615 shares @ $26.00

$249,990
Sell

ROBINS CHAD M · CEO · Chair · Director

2026-08-18 · 278,472 shares @ $24.48

$7M
Sell

HERSHBERG ROBERT · Director

2026-08-18 · 15,664 shares @ $24.41

$382,358
Sell

HERSHBERG ROBERT · Director

2026-08-18 · 15,000 shares @ $24.39

$365,850
Sell

ROBINS CHAD M · CEO · Chair · Director

2026-08-18 · 204 shares @ $25.14

$5,129
Sell

ROBINS CHAD M · CEO · Chair · Director

2026-08-17 · 318,799 shares @ $25.08

$8M
Sell

NEUPERT PETER M · Director

2026-08-17 · 69,690 shares @ $25.16

$2M
Sell

NEUPERT PETER M · Director

2026-08-17 · 40,000 shares @ $25.10

$1M
Sell

NEUPERT PETER M · Director

2026-08-17 · 15,000 shares @ $25.23

$378,450
Sell

ROBINS CHAD M · CEO · Chair · Director

2026-08-17 · 2,525 shares @ $25.57

$64,564
Sell

BOBULSKY SUSAN · Officer

2026-08-10 · 3,000 shares @ $25.00 · pre-planned sale (10b5-1)

$75,000
Sell

BOBULSKY SUSAN · Officer

2026-07-30 · 1,299 shares @ $24.00 · pre-planned sale (10b5-1)

$31,176

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-07-29Miss -87%

Actual EPS -$0.25 · est. -$0.13 · After close

▲ 7.2%

Day 1

+9.3%

Next 20 days

2026-05-05Beat +20%

Actual EPS -$0.13 · est. -$0.16 · After close

▲ 4.7%

Day 1

+25.3%

Next 20 days

2026-02-05Beat +51%

Actual EPS -$0.09 · est. -$0.18 · After close

▼ 4.3%

Day 1

-5.2%

Next 20 days

2025-11-05Beat +143%

Actual EPS $0.06 · est. -$0.14 · After close

▼ 11.5%

Day 1

-5.2%

Next 20 days

2025-08-05Beat +29%

Actual EPS -$0.17 · est. -$0.24 · After close

▲ 5.8%

Day 1

+11.4%

Next 20 days

2025-05-01Beat +35%

Actual EPS -$0.20 · est. -$0.31 · After close

▲ 33.7%

Day 1

-2.9%

Next 20 days

2025-02-11Beat +5%

Actual EPS -$0.23 · est. -$0.24 · After close

▼ 3.2%

Day 1

-5.0%

Next 20 days

2024-11-07Beat +20%

Actual EPS -$0.22 · est. -$0.27 · After close

▲ 3.4%

Day 1

+10.7%

Next 20 days

Listen to the earnings call or read the full report on ADPT's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$4.7B
Next earnings2026-11-04
P/E (price to earnings)-
Forward P/E (on expected earnings)-161.8
Revenue growth (YoY)+21.5%
Earnings growth (YoY)-
Net profit margin-20.7%
ROE-38.8%
Debt to equity (D/E)272%
Dividend yield-
Analyst targets (high / low)$34.00 / $21.00
Number of analysts7
Trend and technical indicators
Trend short / mid / longUptrend ↗ · Uptrend ↗ · Uptrend ↗
RSI72
MA50 / MA200$24.98 / $18.33
Distance from MA200+60.5%
MACDPositive
1-year high / low$29.96 / $12.00
vs. S&P 500 (6 months)+92.1%
Volume vs. average0.76×